| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $65K | +0.0% |
| Cost of Revenue | $5K | +0.0% |
| Gross Profit | $60K | +0.0% |
| R&D Expense | $2.2M | +55.2% |
| SG&A Expense | $5.0M | +25.5% |
| Operating Income | -$7.2M | -34.8% |
| Net Income | -$7.0M | -30.6% |
| EPS (Basic) | -$0.85 | +4.5% |
| EPS (Diluted) | -$0.85 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.4M | +107.1% |
| Current Assets | $5.5M | +100.2% |
| Total Assets | $5.6M | +100.0% |
| Current Liabilities | $588K | +219.0% |
| Total Liabilities | $588K | +219.0% |
| Stockholders' Equity | $5.0M | +91.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.6M | +6.5% |
| Financing Cash Flow | $8.4M | -1.7% |
| +4.5% |